Cargando…
Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic
Autores principales: | Syed, Maha N., Shah, Mohsin, Shin, Daniel B., Wan, Marilyn T., Winthrop, Kevin L., Gelfand, Joel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448776/ https://www.ncbi.nlm.nih.gov/pubmed/32860913 http://dx.doi.org/10.1016/j.jaad.2020.08.095 |
Ejemplares similares
-
The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
por: Syed, Maha N., et al.
Publicado: (2020) -
The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
por: Wan, Marilyn T., et al.
Publicado: (2020) -
Reply to: “Do IL-17 inhibitors increase risk of respiratory tract infections?”
por: Wan, Marilyn T., et al.
Publicado: (2020) -
Pivot Points: Five Decisions Every Successful Leader Must Make
por: Peters, Julia
Publicado: (2014) -
In response to: “Reply to research letter”
por: Wan, Marilyn T., et al.
Publicado: (2020)